This week, the FDA opened applications for its Expedited IND Pilot, quality experts presented at the PDA/FDA Joint Regulatory Conference, and Hovione expanded its spray drying capacity.
News|Articles|February 23, 2017
PTSM: Pharmaceutical Technology Sourcing and Management
- PTSM: Pharmaceutical Technology Sourcing and Management-03-01-2017
- Volume 12
- Issue 3
Metrohm USA Announces Winner of Young Chemist Award
Author(s)Pharmaceutical Technology Editors
Metrohm USA presented the Young Chemist Award to Aldin Malkoc for his work on cooperative, DNA-based molecular elements for electrochemical biosensors.
Advertisement
On Feb. 17, 2017, Metrohm USA announced that Aldin Malkoc is the winner of the company’s 2017 Young Chemist Award. Malkoc is completing his graduate work at Arizona State University where he works under the supervision of professor Michael Caplan, chair of the Biomedical Engineering Department, and assistant professor Jeffrey LaBelle.
Malkoc’s research focuses on cooperative, DNA-based molecular elements for electrochemical biosensors. This rapid, point-of-care, low-cost, and highly specific method of genetic mutation detection is a new technology that has the potential to impact healthcare in developing countries and underrepresented clinics where low-cost and rapid treatment are important.
The Young Chemist Award is open to all undergraduate, graduate, post-graduate, and doctorate students residing and studying in the United States and Canada who are performing novel research in the fields of titration, ion chromatography, spectroscopy, and electrochemistry.
Source: Metrohm USA
Articles in this issue
over 9 years ago
Viewpoint: No Clear Path for Pharma or Outsourcingover 9 years ago
Standards Set Excipient GMPs, But Collaboration is Neededover 9 years ago
Monitoring Supply Chain Risk on a Limited Budgetover 9 years ago
Evaluating E&L Studies for Single-Use Systemsover 9 years ago
PfizerCentreOne Expands Fill/Finish Services in Michiganover 9 years ago
Novasep Opens New Bioconjugation Unit in Franceover 9 years ago
Recipharm Completes Kemwell AcquisitionAdvertisement
Related to this article
Christy Owings, Thermo Fisher, explains clinical trial supply chain risks in Latin America, importer-of-record strategy, AI, and eCOA delays.
PharmTech AI Pulse Check debuts: pharma experts tackle GxP 'slop,' multi-agent validation risk, OCR document mining, personalized mRNA cancer therapy.
Andrea K. Kerrigan, FDA, outlines how validation, data integrity, and QRM determine whether digital tools and AI strengthen or undermine CGMP compliance.
PharmTech spoke with Tara Dougal, event director for pharma at Informa Markets, about trends impacting the pharmaceutical industry and how CPHI Milan is addressing these areas this year.
Andrew Parker, PhD, executive drug development consultant, Quotient Sciences, explains how AI is integrated into pharmaceutical development.
PDA/FDA 2026 session maps the GMP audit lifecycle, root cause to CAPA closure, plus a local vs. above-site decision framework and two case studies.
The recently opened NJ spray drying facility doubles capacity for amorphous solid dispersions, addressing solubility limits in roughly 70% of small-molecule pipelines.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Introducing the "PharmTech AI Pulse Check" Expert Video Series
2
PharmTech Weekly Roundup—September 18, 2026
3
Can AI Agents Satisfy CGMP Documentation Requirements?
4
Two Audit Case Studies Reveal the Cost of Incomplete Corrective Actions
5